login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
ROCKET PHARMACEUTICALS INC (RCKT) Stock News
USA
- NASDAQ:RCKT -
US77313F1066
-
Common Stock
3.19
USD
-0.13 (-3.92%)
Last: 9/25/2025, 8:00:02 PM
3.23
USD
+0.04 (+1.25%)
After Hours:
9/25/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
RCKT Latest News, Press Relases and Analysis
All
Press Releases
6 days ago - By: Kuehn Law, PLLC
Kuehn Law Encourages Investors of Rocket Pharmaceuticals, Inc. to Contact Law Firm
21 days ago - By: Benzinga
- Mentions:
QURE
RARE
LXEO
NGNE
FDA Outlines Process To Speed Up Rare Disease Therapy Approvals
a month ago - By: Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
a month ago - By: Zacks Investment Research
- Mentions:
AMRN
AKRO
ALGS
RCKT Stock Rises as FDA Lifts Clinical Hold on Danon Disease Study
a month ago - By: Benzinga
- Mentions:
CSIQ
SUPX
TEF
COTY
...
Coty, Bilibili, Canadian Solar And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
a month ago - By: Stocktwits
Why Is Rocket Pharma Stock Up 15% Pre-Market Today?
a month ago - By: Stocktwits
- Mentions:
SRPT
Citi Believes FDA May Closely Watch Sarepta’s Safeguards For Gene Therapy In Non-Ambulatory DMD Patients
2 months ago - By: Faruqi & Faruqi, LLP
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals
2 months ago - By: The Gross Law Firm
Class Action Filed Against Rocket Pharmaceuticals, Inc. (RCKT) - August 11, 2025 Deadline to Join - Contact The Gross Law Firm
2 months ago - By: THE ROSEN LAW FIRM, P. A.
RCKT Deadline: RCKT Investors with Losses in Excess of $100K Have Opportunity to Lead Rocket Pharmaceuticals, Inc. Securities Fraud Lawsuit
2 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT
2 months ago - By: Faruqi & Faruqi, LLP
Faruqi & Faruqi Reminds Rocket Pharmaceuticals Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025 - RCKT
2 months ago - By: Berger Montague
DEADLINE NEXT WEEK: Berger Montague Advises Rocket Pharmaceuticals (NASDAQ: RCKT) Investors to Contact the Firm Before August 11, 2025
2 months ago - By: The Law Offices of Frank R. Cruz
Deadline Soon: Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
2 months ago - By: Levi & Korsinsky, LLP
August 11, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against RCKT
2 months ago - By: The Motley Fool
Rocket (RCKT) Q2 Loss Narrows 16%
2 months ago - By: Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Recent Progress
2 months ago - By: The Rosen Law Firm PA
RCKT DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important August 11 Deadline in Securities Class Action – RCKT
2 months ago - By: The Gross Law Firm
Lost Money on Rocket Pharmaceuticals, Inc.(RCKT)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
2 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT
2 months ago - By: Berger Montague
DEADLINE APPROACHING: Berger Montague Advises Rocket Pharmaceuticals (NASDAQ: RCKT) Investors to Inquire About a Securities Fraud Class Action by August 11, 2025
2 months ago - By: THE ROSEN LAW FIRM, P. A.
RCKT Deadline: RCKT Investors with Losses in Excess of $100K Have Opportunity to Lead Rocket Pharmaceuticals, Inc. Securities Fraud Lawsuit
2 months ago - By: Faruqi & Faruqi LLP
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals
2 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT
Please enable JavaScript to continue using this application.